Candidemia Market To Observe Impressive Growth During the Forecast Period (2022-2032), Evaluates DelveInsight | Key Companies – Amplyx Pharmaceuticals, Cidara Therapeutics, Scynexis Inc.

DelveInsight’s “Candidemia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Candidemia, historical and forecasted epidemiology as well as the Candidemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Candidemia Overview

Candidemia is a life-threatening bloodstream infection. The incidence of Candida bloodstream infection is bimodal, with the elderly and very young having the highest risk of any population suffering from this disease.

Some of the key facts of the Candidemia Market Report:

• Candidemia market size is anticipated to increase with a significant CAGR during the study period 2019-32.
• The total diagnosed cases of Candidemia in the 7MM were 40,000+ in 2020.
• Candidemia epidemiology based on gender analyzed that Candidemia diagnosis is more common in males as compared to females.
• People of Ages 65 and above are the most prevalent population to be affected by Candidemia.
• Candidemia key companies such as Amplyx Pharmaceuticals, Cidara Therapeutics, Scynexis Inc. are working towards developing the Candidemia drugs.
• Candidemia emerging therapies like Rezafungin (CD101), Ibrexafungerp (SCY-078), Fosmanogepix (APX001) are expected to change the dynamics of the Candidemia market.
• The mortality rate for candidemia is 30–60%.

Request a sample for the Candidemia Market Report

Key benefits of the Candidemia Market report:

1. Candidemia market report covers a descriptive overview and comprehensive insight of the Candidemia Epidemiology and Candidemia market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2. The Candidemia market report provides insights on the current and emerging therapies.
3. Candidemia market report provides a global historical and forecasted market covering drug outreach in 7MM.
4. The Candidemia market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Candidemia market.

Got queries? Click here to know more about the Candidemia Market Landscape

The Report Covers the Candidemia Epidemiology, Segmented by –

• Total Incident Cases of Candidemia in the 7MM (2019–2032)
• Gender-specific Cases of Candidemia in the 7MM (2019–2032)
• Age-specific Cases of Candidemia in the 7MM (2019–2032)
• Mutation-specific Cases of Candidemia in the 7MM (2019–2032)
• Treated Cases of Candidemia by the line of therapies in the 7MM (2019–2032)
• Treated Cases of Candidemia by status in the 7MM (2019–2032)

Candidemia Market

The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Candidemia market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report gives complete detail of the Candidemia market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MOA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Candidemia Drugs Uptake and Pipeline Development Activities

The drugs’ uptake section focuses on the rate of uptake of the potential drugs recently launched in the Candidemia market or expected to be launched during the study period. The analysis covers the Candidemia market uptake by drugs, patient uptake by therapies, and sales of each drug.

The report’s drugs uptake section helps in understanding the drugs with the most rapid uptake and reasons behind the maximal use of new drugs and allows the comparison of the drugs based on market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Candidemia Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Candidemia Market Drivers

• Upcoming launch of novel, new class antifungal Candidemia drugs
• Increasing awareness for treating Candidemia
• Personalized Candidemia treatments

Candidemia Market Barriers

• Minimizing the use of antimicrobial
• Lack of adequate Candidemia diagnosis
• Lack of country-specific Candidemia guidelines

Learn more by requesting for sample @ Candidemia Market Landscape

Candidemia Pipeline Therapies and Key Companies

• APX001: Pfizer/Amplyx Pharmaceuticals
• Rezafungin / CD101: Cidara Therapeutics
• SCY-078: Scynexis

Table of Contents

1. Candidemia Market Report Introduction
2. Executive Summary for Candidemia
3. SWOT analysis of Candidemia
4. Candidemia Patient Share (%) Overview at a Glance
5. Candidemia Market Overview at a Glance
6. Candidemia Disease Background and Overview
7. Candidemia Epidemiology and Patient Population
8. Country-Specific Patient Population of Candidemia
9. Candidemia Current Treatment and Medical Practices
10. Candidemia Unmet Needs
11. Candidemia Emerging Therapies
12. Candidemia Market Outlook
13. Country-Wise Candidemia Market Analysis (2019–2032)
14. Candidemia Market Access and Reimbursement of Therapies
15. Candidemia Market drivers
16. Candidemia Market barriers
17. Candidemia Appendix
18. Candidemia Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Click here to read more about Candidemia Market Outlook 2032

Related Reports:

Candidemia Pipeline

“Candidemia Pipeline Insight, 2023“ report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Candidemia market. A detailed picture of the Candidemia pipeline landscape is provided, which includes the disease overview and Candidemia treatment guidelines.

Candidemia Epidemiology

DelveInsight’s ‘Candidemia Epidemiology Forecast to 2032‘ report delivers an in-depth understanding of the disease, historical and forecasted Candidemia epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Trending Reports by DelveInsight:

· Asthma Diagnostic Devices Market
· Chronic Obstructive Pulmonary Disease Treatment Devices Market
· Airway Management Devices Market
· Cough Assist Devices Market
· Pulse Oximeters Market
· Hemodialysis Catheter Devices Market
· Chronic Spontaneous Urticaria Market
· Gender Dysphoria Market
· Germany Healthcare Outlook
· Biopsy Devices Pipeline Insight
· Bacterial Conjunctivitis Market
· Infliximab Biosimilar Insight
· Eosinophilic Asthma Market
· Cushing Syndrome Market
· Functional Dyspepsia Market
· Peripherally Inserted Central Catheters (PICC) Devices Market

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact

Company Name: DelveInsight Business Research LLP
Contact Person: Navdha Goel
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com